Caplight Directory>Companies>Fesarius Therapeutics-preview>Fesariustherapeutics


Fesarius Therapeutics

Fesarius Therapeutics

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.fesariustherapeutics.com/

Last Round

Convertible Debt

Nov 1, 2023

Total Funding Raised

$8.63M

Momentum Score

25 /100

Company Overview

Fesarius Therapeutics is a bioregenerative medical technology company that develops solutions for wound care, reconstructive surgery, and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

advanced wound careregenerative medicinedermal regeneration templatecollagen hydrogeltissue engineeringskin substitutetissue scaffoldfull-thickness skin lossbioregenerative technologymedical deviceskin graft alternativereconstructive surgerybiomaterialFDA 510(k) clearanceburn treatmentchronic ulcer treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fesarius Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fesarius Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtNov 1, 2023
GrantAug 16, 2023
GrantAug 8, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Tom Roueche

President And Chief Executive Officer

Executive Team

Fesarius Therapeutics Investors

Notable investors and investment history

InvestorRounds
National Institute of Arthritis and Musculoskeletal and Skin DiseasesGrant
NIH RADxGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 23, 2026

    Monthly visitors increased 230% MoM.

  • May 4, 2025

    Monthly visitors grew 240% MoM, from 324 to 1.1K.

View all signals

Fesarius Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fesarius Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fesarius Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range15
Year Founded2015
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.